GlassScriptPhysician profile
Aparajitha K Verma
NPI 1750592408
$2,064.97
in general payments reported to CMS, 2019-2025
20 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $174 · 2021: $130 · 2023: $442 · 2024: $182 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.23 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $327.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $284.23 | 2020-2021 | |
| Inspire Medical Systems, INC. | $274.68 | 2023-2025 | Inspire |
| Sk Life Science, INC. | $248.78 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $189.99 | 2023 | |
| Amneal Pharmaceuticals LLC | $129.33 | 2024 | Crexont |
| Greenwich Biosciences, INC. | $120.09 | 2019 | |
| Zoll Respicardia, INC. | $107.90 | 2023 | Remede System |
| Harmony Biosciences LLC | $96.19 | 2025 | |
| Novo Nordisk INC | $66.21 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $33.28 | 2025 | Lumryz |
| Merz North America, INC. | $24.29 | 2019 | |
| Abbvie INC. | $22.86 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $21.32 | 2019 | |
| Amgen INC. | $20.87 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $20.70 | 2019 | |
| Ambu INC. | $19.41 | 2021 | |
| Avanir Pharmaceuticals, INC. | $19.35 | 2019 | |
| Biogen, INC. | $19.24 | 2019 | |
| Grifols USA, LLC | $19.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aparajitha Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.